Research Roundup

Debbie Rigby takes a look at the latest in research news

Evaluation of the first pharmacist-administered vaccinations in Western Australia

This initial evaluation of WA pharmacist vaccination services showed that vaccine delivery was safe. Convenience and accessibility were important aspects in usage of services. There is scope to expand pharmacist vaccination services to other vaccines and younger children; however, government funding to pharmacists needs to be considered.

BMJ Open 2016;6:e011948.


Epilepsy during pregnancy: focus on management strategies

Patients with epilepsy who become pregnant are at risk of complications, including changes in seizure frequency, maternal morbidity and mortality, and congenital anomalies due to antiepileptic drug exposure. Appropriate management of epilepsy during pregnancy may involve frequent monitoring of antiepileptic drug serum concentrations, potential preconception switching of antiepileptic medications, making dose adjustments, minimizing peak drug concentration with more frequent dosing, and avoiding potentially teratogenic medications.

International Journal of Women’s Health 2016;8:505-17.


Long-term safety of tiotropium delivered by Respimat® SoftMist™ Inhaler: patient selection and special considerations

Tiotropium bromide is a long-acting inhaled muscarinic antagonist used in patients with chronic respiratory disease. Respimat® SoftMist™ Inhaler is a multidose aqueous solution to deliver the drug as a fine mist. Potential benefits include more efficient drug deposition throughout the respiratory tract, reduced systemic exposure, and greater ease of use and patient satisfaction compared with the use of HandiHaler DPI.

Therapeutics and Clinical Risk Management 2016;1:1433-44.


Management of hypertension in an Australian community pharmacy setting – patients’ beliefs and perspectives

A small (n=18) qualitative study of consumers in selected metropolitan regions in Sydney has shown that patients are extremely positive about the role of, and their experience of, the pharmacy-based hypertension management service. Most patients regarded the service to be valuable but saw it as complementary, rather than as an alternative, to GP services. Good rapport with the pharmacist and a long-term relationship underpin patient engagement in such services.

International Journal of Pharmacy Practice 2016.





Previous The pharmacy of the future
Next Forum: should pharmacists be selling OTC NSAIDs?

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.

No Comment

Leave a reply